Every medicine authorised for the Irish market — 10,165 products with active substances, licence holders, dosage forms and prescription status.
| Medicine | Active substance | Licence holder | Status |
|---|---|---|---|
| Flixotide Evohaler 50 micrograms per metered dose, Pressurised Inhalation Suspension PA1077/044/013 |
Fluticasone propionate | GlaxoSmithKline (Ireland) Limited | Marketed |
| Flolan 0.5 mg powder and solvent for solution for infusion PA1077/058/002 |
Epoprostenol | GlaxoSmithKline (Ireland) Limited | Marketed |
| Flolan 1.5 mg powder and solvent for solution for infusion PA1077/058/001 |
Epoprostenol | GlaxoSmithKline (Ireland) Limited | Marketed |
| Fluarix Tetra suspension for injection in pre-filled syringe Influenza vaccine (split virion, inactivated) PA1077/134/001 |
A/Victoria/4897/2022 (H1N1)pdm09-like strain (A/Victoria/4897/2022, IVR-238, A/Darwin/9/2021 (H3N2)-like strain (A/Darwin/6/2021, IVR-227), B/Austria/1359417/2021 - like strain (B/Austria/1359417/2021, BVR-26) [Victoria lineage], B/PHUKET/3073/2013 -LIKE STRAIN (B/PHUKET/3073/2013, WILD TYPE) | GlaxoSmithKline (Ireland) Limited | Not marketed |
| Havrix Junior Monodose Vaccine. Hepatitis A Vaccine (Inactivated, Adsorbed). 720 ELISA units/ 0.5ml Suspension for injection in a pre-filled syringe PA1077/026/001 |
Hepatitis A antigen | GlaxoSmithKline (Ireland) Limited | Marketed |
| Havrix Monodose Vaccine. Hepatitis A Vaccine (inactivated, adsorbed), 1440 ELISA units/ 1ml Suspension for injection in a pre-filled syringe PA1077/026/002 |
Aluminium, Hepatitis A antigen | GlaxoSmithKline (Ireland) Limited | Not marketed |
| Hiberix. Haemophilus Type b (Hib) vaccine.Powder and Solvent for Solution for Injection PA1077/027/001 |
Haemophilus influenzae type b polysaccharide | GlaxoSmithKline (Ireland) Limited | Not marketed |
| Imigran 10 mg Nasal Spray, Solution PA1077/008/003 |
Sumatriptan | GlaxoSmithKline (Ireland) Limited | Marketed |
| Imigran 20 mg nasal spray, solution PA1077/008/004 |
Sumatriptan | GlaxoSmithKline (Ireland) Limited | Marketed |
| Imigran Ftab 100 mg film-coated tablets PA1077/008/007 |
Sumatriptan | GlaxoSmithKline (Ireland) Limited | Marketed |
| Imigran Ftab 50 mg film-coated tablets PA1077/008/006 |
Sumatriptan | GlaxoSmithKline (Ireland) Limited | Marketed |
| Incruse Ellipta 55 micrograms inhalation powder, pre-dispensed EU/1/14/922/001-003 |
Umeclidinium bromide | GlaxoSmithKline Trading Services Limited | — |
| Infanrix hexa EU/1/00/152/001 |
Haemophilus influenzae, Pertussis toxoid, Tetanus toxoid, Polysaccharide-k, Diphtheria toxoid | GlaxoSmithKline Biologicals S.A. | — |
| Infanrix hexa EU/1/00/152/002 |
Haemophilus influenzae, Hbs ag, Tetanus toxoid, Pertussis toxoid, Filamentous haemagglutinin | GlaxoSmithKline Biologicals S.A. | — |
| Infanrix hexa EU/1/00/152/003 |
Haemophilus influenzae, Pertactin, Diphtheria toxoid, Polysaccharide-k, Tetanus toxoid | GlaxoSmithKline Biologicals S.A. | — |
| Infanrix hexa EU/1/00/152/004 |
Haemophilus influenzae, Pertactin, Diphtheria toxoid, Polysaccharide-k, Tetanus toxoid | GlaxoSmithKline Biologicals S.A. | — |
| Infanrix hexa EU/1/00/152/005 |
Pertactin, Pertussis toxoid, Hbs ag, Diphtheria toxoid, Filamentous haemagglutinin | GlaxoSmithKline Biologicals | — |
| Infanrix hexa EU/1/00/152/006 |
Filamentous haemagglutinin, Polysaccharide-k, Diphtheria toxoid, Haemophilus influenzae, Tetanus toxoid | GlaxoSmithKline Biologicals S.A. | Marketed |
| Infanrix hexa EU/1/00/152/007 |
Haemophilus influenzae, Pertactin, Diphtheria toxoid, Polysaccharide-k, Tetanus toxoid | GlaxoSmithKline Biologicals S.A. | — |
| Infanrix hexa EU/1/00/152/008 |
Haemophilus influenzae, Pertactin, Diphtheria toxoid, Polysaccharide-k, Tetanus toxoid | GlaxoSmithKline Biologicals S.A. | — |
| Infanrix hexa EU/1/00/152/009 |
Haemophilus influenzae, Pertactin, Diphtheria toxoid, Polysaccharide-k, Tetanus toxoid | GlaxoSmithKline Biologicals S.A. | — |
| Infanrix hexa EU/1/00/152/010 |
Haemophilus influenzae, Pertactin, Diphtheria toxoid, Polysaccharide-k, Tetanus toxoid | GlaxoSmithKline Biologicals S.A. | — |
| Infanrix hexa EU/1/00/152/011 |
Haemophilus influenzae, Pertactin, Diphtheria toxoid, Polysaccharide-k, Tetanus toxoid | GlaxoSmithKline Biologicals S.A. | — |
| Infanrix hexa EU/1/00/152/012 |
Haemophilus influenzae, Pertactin, Diphtheria toxoid, Polysaccharide-k, Tetanus toxoid | GlaxoSmithKline Biologicals | — |
| Infanrix hexa EU/1/00/152/013 |
Haemophilus influenzae, Pertactin, Diphtheria toxoid, Polysaccharide-k, Tetanus toxoid | GlaxoSmithKline Biologicals S.A. | — |
| Infanrix hexa EU/1/00/152/014 |
Haemophilus influenzae, Pertactin, Diphtheria toxoid, Polysaccharide-k, Tetanus toxoid | GlaxoSmithKline Biologicals S.A. | — |
| Infanrix hexa EU/1/00/152/015 |
Haemophilus influenzae, Pertactin, Diphtheria toxoid, Polysaccharide-k, Tetanus toxoid | GlaxoSmithKline Biologicals S.A. | — |
| Infanrix hexa EU/1/00/152/016 |
Haemophilus influenzae, Pertactin, Diphtheria toxoid, Polysaccharide-k, Tetanus toxoid | GlaxoSmithKline Biologicals S.A. | — |
| IPV Infanrix suspension for injection in pre-filled syringe Diphtheria, tetanus, pertussis (acellular, component) and poliomyelitis (inactivated) vaccine (adsorbed) PA1077/108/001 |
Pertussis toxoid, Filamentous haemagglutinin, Pertactin, Diphtheria toxoid, Tetanus toxoid | GlaxoSmithKline (Ireland) Limited | Not marketed |
| IPV-Boostrix– Suspension for injection in a pre-filled syringeDiphtheria, tetanus, pertussis (acellular, component) and poliomyelitis (inactivated) vaccine (adsorbed, reduced antigen(s) content) PA1077/101/001 |
Diphtheria toxoid, Tetanus toxoid, Pertussis toxoid, Filamentous haemagglutinin, Pertactin | GlaxoSmithKline (Ireland) Limited | Not marketed |
| Iruxol Mono 1.2 U/g Ointment PA22696/001/001 |
Protease, Clostridiopeptidase a | Smith & Nephew GmbH | Marketed |
| JEMPERLI 500 mg concentrate for solution for infusion EU/1/21/1538/001 |
Dostarlimab | GlaxoSmithKline Trading Services Limited | — |
| Lamictal 100 mg chewable/dispersible tablets PA1077/061/009 |
Lamotrigine | GlaxoSmithKline (Ireland) Limited | Marketed |
| Lamictal 100 mg tablets PA1077/061/003 |
Lamotrigine | GlaxoSmithKline (Ireland) Limited | Marketed |
| Lamictal 2 mg chewable/dispersible tablets PA1077/061/005 |
Lamotrigine | GlaxoSmithKline (Ireland) Limited | Marketed |
| Lamictal 200 mg chewable/dispersible tablets PA1077/061/010 |
Lamotrigine | GlaxoSmithKline (Ireland) Limited | Marketed |
| Lamictal 200 mg tablets PA1077/061/004 |
Lamotrigine | GlaxoSmithKline (Ireland) Limited | Marketed |
| Lamictal 25 mg chewable/dispersible tablets PA1077/061/007 |
Lamotrigine | GlaxoSmithKline (Ireland) Limited | Marketed |
| Lamictal 25 mg tablets PA1077/061/001 |
Lamotrigine | GlaxoSmithKline (Ireland) Limited | Marketed |
| Lamictal 5 mg chewable/dispersible tablets PA1077/061/006 |
Lamotrigine | GlaxoSmithKline (Ireland) Limited | Marketed |
| Lamictal 50 mg chewable/dispersible tablets PA1077/061/008 |
Lamotrigine | GlaxoSmithKline (Ireland) Limited | Marketed |
| Lamictal 50 mg tablets PA1077/061/002 |
Lamotrigine | GlaxoSmithKline (Ireland) Limited | Marketed |
| LAVENTAIR ELLIPTA 55 micrograms/22 micrograms inhalation powder, pre-dispensed EU/1/14/899/001-003 |
Umeclidinium bromide, Vilanterol trifenatate | GlaxoSmithKline Trading Services Limited | — |
| Lyclear 5% w/w Dermal Cream PA1077/066/001 |
Permethrin | GlaxoSmithKline (Ireland) Limited | Marketed |
| Malarone 250 mg/100 mg film-coated tablets PA1077/111/001 |
Atovaquone, PROGUANIL HYDROCHLORIDE | GlaxoSmithKline (Ireland) Limited | Marketed |
| Menitorix powder and solvent for solution for injection. Haemophilus type b and Meningococcal group C conjugate vaccine PA1077/116/001 |
Conjugate of haemophilus influenzae type b capsular polysaccharide (polyribosylribitol phosphate) and tetanus, Conjugate of neisseria meningitides c capsular polysaccharide and tetanus toxoid (mean tt/ps ratio :1) | GlaxoSmithKline (Ireland) Limited | Not marketed |
| Menjugate 10 micrograms suspension for injection Meningococcal group C conjugate vaccine PA0919/004/003 |
Meningococcal group c oligosaccharide, Corynebacterium diphtheriae crm197 protein | Glaxosmithkline Vaccines S.r.l. | — |
| Menjugate 10 micrograms suspension for injection Meningococcal group C conjugate vaccine PA0919/004/004 |
Meningococcal group c oligosaccharide, Corynebacterium diphtheriae crm197 protein | Glaxosmithkline Vaccines S.r.l. | — |
| Menveo EU/1/10/614/002-004 |
N. MENINGITIDIS GROUP A OLIGOSACCHARIDE CONJUGATED CRM197, N. MENINGITIDIS GROUP C (STRAIN C11) POLYSACCHARIDE CONJUGATED CRM197, N. MENINGITIDIS GROUP W135 OLIGOSACCHARIDE CONJUGATED CRM197, MENINGOCOCCAL GROUP Y OLIGOSACCHARIDE CONJUGATED TO CORYNEBACTERIUM DIPHTHERIAE CRM197 PROTEIN | Glaxosmithkline Vaccines S.r.l. | — |
| Menveo powder and solution for solution for injection EU/1/10/614/002-003 |
Meningococcal group y oligosacchardie, Meningococcal group a oligosaccharide, Meningococcal group c oligosaccharide, Meningococcal group w-135 oligosaccharide | Glaxosmithkline Vaccines S.r.l. | — |
Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 12 August 2026).
Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.